netrashetty
Netra Shetty
ZOMM, LLC, headquartered in Tulsa, Oklahoma, is an emerging technology company specializing in the design and manufacturing of wireless and hands-free devices for mobile phones and other consumer electronics. Its first product, the ZOMM Wireless Leash, uses Bluetooth to prevent mobile phone loss using various indicators: vibration, lights and sound. ZOMM also provides hands-free communication with speakerphone capabilities and provides emergency dialing to 911 or other user-selected numbers.[1][2]
n 2004, Korean scientist Dr. Hwang Woo-suk, a specialist in veterinary medicine and animal cloning, and his research team, claimed to have created the world's first stem cells from a cloned human embryo. The implications were huge. The ability to clone stem cells suggested the potential for human cloning and the use of stem cell therapy to treat incurable diseases. However, an eight-member peer review panel at Seoul National University, where most of the research was conducted, concluded in January 2006 that the research claims, published in the prominent journal Science, were fraudulent. The researchers had not, in fact, successfully cloned human embryonic stem cells.
• The review panel also found that a follow-up article by Dr. Hwang's team, published in May 2005, was fraudulent. According to a Jan. 10 article in The Washington Post, "In that article, the researchers claimed to have created 11 embryonic stem-cell colonies said to be exact genetic matches of patients who might have benefited from the cells, which have the capacity to repair damaged tissues. Independent evidence, however, failed to find evidence that any of the stem cells had been made from clones, discrediting what had been considered one of the major scientific discoveries of 2005."
• Shortly after the incident with Dr. Hwang and his research team in South Korea, news of another medical fraud surfaced, this time in Norway. Jon Sudbo, a researcher at Norway's Comprehensive Cancer Center, reportedly admitted to fabricating research results to show that common over-the-counter painkillers like ibuprofen lowered the risk of oral cancer but increased the risk of heart problems and death from heart disease. As it turns out, Sudbo's study, published in the prestigious British medical journal The Lancet, was completely fictitious. Apparently, Sudbo made up patients for his supposed review of 454 people with oral cancer.
• The Lancet published Sudbo's study because it appeared to offer important information about pain relievers called non-steroidal anti-inflammatories, or NSAIDs, but Lancet editor Richard Horton later told the Associated Press that Sudbo was a "very clever fabricator," saying he "fooled his colleagues, he fooled his hospital, he fooled his funding agency, he fooled the journal."
• At the time of this writing, fresh concerns about Sudbo's research are being raised over papers published in the New England Journal of Medicine in April 2001 and April 2004 and the Journal of Clinical Oncology in October 2005. According to reports, Sudbo admitted those studies, both on oral cancer, were fabricated, as well.
• Another recent incidence of medical fraud, this one in the United States, involved Eric T. Poehlman, a top obesity researcher who apparently fabricated data in medical journals and on federal grant applications while working at the University of Vermont. According to the Boston Globe, Poehlman altered and invented research results between 1992 and 2002, during which period he published more than 200 articles. Among the fraudulent research was a study linking menopause to declines in women's health, which was published in The Annals of Internal Medicine in 1995 and retracted in 2003.
• Poehlman was "outted" when Walter F. DeNino -- a former University of Vermont lab technician who once viewed Poehlman as a mentor -- discovered something suspicious in his research. In 2000, Poehlman asked DeNino to analyze some preliminary test results on the effects of menopause on women's health. When, contrary to Poehlman's expectations, the analysis showed some women actually experienced health improvements after menopause, he changed the test results to fit his hypothesis. DeNino then blew the whistle on his one-time mentor. In 2005, 49-year-old Poehlman resigned from his position at Université de Montréal, where he had worked since 2001. Under a plea agreement with federal prosecutors, he will be barred for life from receiving federal funding and will be required to pay back $180,000 and plead guilty to a criminal fraud charge, which could mean jail time, according to the Boston Globe.
• Finally, in October 2005, the Boston Globe reported that an associate professor at the prestigious Massachusetts Institute of Technology was fired for scientific research fraud. Luk Van Parijs, 35, reportedly fabricated data in two journal articles he co-wrote in the late 1990s, while working as a graduate student at Brigham and Women's Hospital, studying the immune system. He also admitted to fabricating and falsifying data in a paper he wrote at MIT, and two of his other papers are under investigation by the California Institute of Technology at the time of this writing.
n 2004, Korean scientist Dr. Hwang Woo-suk, a specialist in veterinary medicine and animal cloning, and his research team, claimed to have created the world's first stem cells from a cloned human embryo. The implications were huge. The ability to clone stem cells suggested the potential for human cloning and the use of stem cell therapy to treat incurable diseases. However, an eight-member peer review panel at Seoul National University, where most of the research was conducted, concluded in January 2006 that the research claims, published in the prominent journal Science, were fraudulent. The researchers had not, in fact, successfully cloned human embryonic stem cells.
• The review panel also found that a follow-up article by Dr. Hwang's team, published in May 2005, was fraudulent. According to a Jan. 10 article in The Washington Post, "In that article, the researchers claimed to have created 11 embryonic stem-cell colonies said to be exact genetic matches of patients who might have benefited from the cells, which have the capacity to repair damaged tissues. Independent evidence, however, failed to find evidence that any of the stem cells had been made from clones, discrediting what had been considered one of the major scientific discoveries of 2005."
• Shortly after the incident with Dr. Hwang and his research team in South Korea, news of another medical fraud surfaced, this time in Norway. Jon Sudbo, a researcher at Norway's Comprehensive Cancer Center, reportedly admitted to fabricating research results to show that common over-the-counter painkillers like ibuprofen lowered the risk of oral cancer but increased the risk of heart problems and death from heart disease. As it turns out, Sudbo's study, published in the prestigious British medical journal The Lancet, was completely fictitious. Apparently, Sudbo made up patients for his supposed review of 454 people with oral cancer.
• The Lancet published Sudbo's study because it appeared to offer important information about pain relievers called non-steroidal anti-inflammatories, or NSAIDs, but Lancet editor Richard Horton later told the Associated Press that Sudbo was a "very clever fabricator," saying he "fooled his colleagues, he fooled his hospital, he fooled his funding agency, he fooled the journal."
• At the time of this writing, fresh concerns about Sudbo's research are being raised over papers published in the New England Journal of Medicine in April 2001 and April 2004 and the Journal of Clinical Oncology in October 2005. According to reports, Sudbo admitted those studies, both on oral cancer, were fabricated, as well.
• Another recent incidence of medical fraud, this one in the United States, involved Eric T. Poehlman, a top obesity researcher who apparently fabricated data in medical journals and on federal grant applications while working at the University of Vermont. According to the Boston Globe, Poehlman altered and invented research results between 1992 and 2002, during which period he published more than 200 articles. Among the fraudulent research was a study linking menopause to declines in women's health, which was published in The Annals of Internal Medicine in 1995 and retracted in 2003.
• Poehlman was "outted" when Walter F. DeNino -- a former University of Vermont lab technician who once viewed Poehlman as a mentor -- discovered something suspicious in his research. In 2000, Poehlman asked DeNino to analyze some preliminary test results on the effects of menopause on women's health. When, contrary to Poehlman's expectations, the analysis showed some women actually experienced health improvements after menopause, he changed the test results to fit his hypothesis. DeNino then blew the whistle on his one-time mentor. In 2005, 49-year-old Poehlman resigned from his position at Université de Montréal, where he had worked since 2001. Under a plea agreement with federal prosecutors, he will be barred for life from receiving federal funding and will be required to pay back $180,000 and plead guilty to a criminal fraud charge, which could mean jail time, according to the Boston Globe.
• Finally, in October 2005, the Boston Globe reported that an associate professor at the prestigious Massachusetts Institute of Technology was fired for scientific research fraud. Luk Van Parijs, 35, reportedly fabricated data in two journal articles he co-wrote in the late 1990s, while working as a graduate student at Brigham and Women's Hospital, studying the immune system. He also admitted to fabricating and falsifying data in a paper he wrote at MIT, and two of his other papers are under investigation by the California Institute of Technology at the time of this writing.
Last edited: